Sarah J. Augood

Overview

Best Publications

• Striatal interneurones : chemical, physiological and morphological characterization

  Yasuo Kawaguchi;Charles J. Wilson;Sarah J. Augood;Piers C. Emson

  1450
  Citations

• Regional and cellular gene expression changes in human Huntington's disease brain.

  Angela Kaye Hodges;Andrew D. Strand;Aaron K. Aragaki;Alexandre Kuhn

  951
  Citations

• Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease.

  Paolo Guidetti;Ruth E Luthi-Carter;Sarah J Augood;Robert Schwarcz

  351
  Citations

• Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage

  Alexandre Kuhn;Darlene R. Goldstein;Angela Hodges;Angela Hodges;Andrew D. Strand

  312
  Citations

• Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia

  Tohru Ohnuma;Sarah J Augood;Heii Arai;Peter J McKenna

  290
  Citations

• Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease

  Steven M. Solano;David W. Miller;Sarah J. Augood;Anne B. Young

  275
  Citations

• Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain

  Peggy F. Shelbourne;Christine Keller-McGandy;Wenya Linda Bi;Song-Ro Yoon

  258
  Citations

• Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

  S. J. Augood;R. L. M. Faull;P. C. Emson

  245
  Citations

• Gene expression profiling in the post-mortem human brain--no cause for dismay.

  S. Bahn;S.J Augood;M. Ryan;D.G. Standaert

  214
  Citations

• TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion.

  Kevin Rostasy;Sarah J. Augood;Jeffrey W. Hewett;Joanne Chung On Leung

  210
  Citations

• Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellularin situ hybridization study

  S.J. Augood;R.L.M. Faull;D.R. Love;P.C. Emson

  201
  Citations

• Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain.

  Sarah J. Augood;Deborah M. Martin;Laurie J. Ozelius;Xandra O. Breakefield

  190
  Citations

• Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABAA receptor α-1 subunit messenger RNA and human GABA transporter-1 (hGAT-1) messenger RNA expression

  T. Ohnuma;T. Ohnuma;S.J. Augood;H. Arai;P.J. McKenna

  181
  Citations

• Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.

  M.-T. Herrero;M.-T. Herrero;S.J. Augood;E.C. Hirsch;F. Javoy-Agid

  162
  Citations

• Expression of the early‐onset torsion dystonia gene (DYT1) in human brain

  Sarah J. Augood;John B. Penney;Ingrid K. Friberg;Xandra O. Breakefield

  153
  Citations

• Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment.

  D. S. Albers;S. J. Augood;L. C. H. Park;S. E. Browne;S. E. Browne

  153
  Citations

• Adenosine A2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: a co-expression study.

  Sarah J. Augood;Piers C. Emson

  150
  Citations

• Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study.

  Sarah J Augood;Z Hollingsworth;D S Albers;L Yang

  145
  Citations

• Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease

  K.A. Harrington;S.J. Augood;A.E. Kingsbury;O.J.F. Foster

  135
  Citations

• Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1

  Birgit Zucker;Ruth Luthi-Carter;Jibrin A. Kama;Anthone W. Dunah

  116
  Citations

• Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data

  Lesley Jones;Darlene R. Goldstein;Gareth P. Hughes;Andrew Strand

  55
  Citations